Skip to main content
Boots and medical cannabis: what it could mean for patients | PatientsCann UK®
Independent view PatientsCann UK® has no commercial link with Boots or SureLeaf, and we are not recommending any provider. This is not medical or legal advice.

Why it matters

A name you see on every high street

Medical cannabis has been legal to prescribe in the UK since November 2018. Eight years on, most patients still get it from small private clinics many people have never heard of. Many of us were told to keep quiet about it. Some of us were told by family, friends or even doctors that it could not be real medicine.

This morning, LBC reported that Boots is set to become the first UK high street pharmacy to prescribe cannabis privately (Swarbrick, 2026). The service, SureLeaf, is already live on the Boots Online Doctor website.

We have watched this sector grow for years. We have seen good clinics and bad ones, fair prices and unfair ones. When a name most families trust starts to offer the same medicine many of us rely on, it changes the conversation. It tells people this is healthcare, not something to hide.

When the chemist your mum uses offers the same medicine you have been defending for years, the stigma starts to lose its grip.
Mohammad Wasway, Managing Director, PatientsCann UK®

Wider access

Why this could help patients

More people will hear about it

Many people living with chronic pain, anxiety or poor sleep still do not know a legal option exists. A household name brings that knowledge to people a small clinic would never reach.

A route people feel safe using

For a lot of patients, the first worry is “is this legitimate?” A recognised and regulated organisation can make that first step feel less risky, for patients and for the people around them.

Easier conversations

Telling an employer, a landlord, a GP or a police officer that your medicine is prescribed is often met with doubt. A familiar name will not fix that alone, but it may help people take patients more seriously.

Higher standards across the sector

When a large, regulated healthcare provider joins a market, others are pushed to raise their game on safety, service and price. Patients should feel that benefit wherever they get their prescription.

What we hope for

From a screen to the high street

SureLeaf is online only for now. You check if you are eligible, share your medical history, have a video consultation, and your medicine is delivered to your door (Boots Online Doctor, 2026a). For many patients that works well, especially those who struggle to get out.

But not everyone is comfortable online. Some older patients, disabled patients and people without good internet are shut out of a system that only works through a screen. Boots already has pharmacists and consultation rooms on high streets across the country. That puts it in a position no small clinic can match.

In-person appointments

We would love to see SureLeaf grow to offer face-to-face appointments in store, where patients can sit down with a clinician or pharmacist, ask questions and get support in person. For many people, talking to someone face to face is what builds trust.

Seeing your medicine before you buy

Anyone prescribed flower knows the problem. You choose a product from a list, often with little more than a name, a THC figure and a price. It usually comes in a 10 gram tub or larger, and you pay for it before you have seen it, smelt it or know whether it suits you. If it arrives poor quality, many patients feel they have no way back.

A high street pharmacy network could change that. Imagine being able to look at a product in a regulated pharmacy, ask the pharmacist about it, and start with a smaller amount before committing to a full tub. Something closer to a dispensary, but run within UK medicines law and with clinical oversight. It would need the regulators and Boots to want it, but patients have been asking for this for years.

Our hope. These are ideas, not plans Boots has announced. We will be asking Boots whether in-person appointments and a way for patients to see their medicine before buying are on the table.

Our view

What we still want to know

Welcoming this does not mean we stop asking questions. These are the ones we think patients deserve clear answers to.

Who makes the first prescription?
By law, a first prescription must come from a doctor on the GMC Specialist Register, and SureLeaf’s own FAQ says so. Both doctors named on its website are GPs (Boots Online Doctor, 2026b). We would like the specialists to be named.
How much choice will patients have?
SureLeaf uses one UK supplier, which it does not name. One supplier can mean fewer products to choose from than at other clinics.
What about younger adults?
LBC reports that patients must be over 25 (Swarbrick, 2026). If so, adults aged 18 to 24 will still need to go elsewhere.

The facts

SureLeaf in brief

  • Who runs it: Boots Online Doctor, run by Boots Digital Health Ltd, which is registered with the Care Quality Commission (Care Quality Commission, 2026).
  • Who it is for: people whose symptoms have not responded to usual treatment, including many chronic pain conditions, generalised anxiety disorder and insomnia (Boots Online Doctor, 2026a).
  • Costs: a £89 one-month trial including a 10ml oil, or a £99 annual plan with four follow-ups. Medicine is extra: flower from £38, oil from £35 (Boots Online Doctor, 2026a).
  • Medicine: UK-grown, from one supplier, dispensed by a GPhC-registered pharmacy and delivered to your door.

If you are already prescribed, you do not need to move. Compare prices, choice and support before you change, and keep copies of your prescription and dispensing records. Our clinics and pharmacies directory lists SureLeaf alongside every other provider we know of.

Tell us what you think

Would you use a high street service? Would seeing your medicine before you buy make a difference to you? Your views shape what we ask for.

References

References follow the Harvard style.

  1. Boots Online Doctor (2026a) Medical cannabis treatment service. Available at: onlinedoctor.boots.com/sureleaf/medical-cannabis (Accessed: 16 November 2026).
  2. Boots Online Doctor (2026b) Dr Rachel Williams. Available at: onlinedoctor.boots.com/clinician-bio/dr-rachel-williams (Accessed: 16 November 2026).
  3. Care Quality Commission (2026) Boots Online Doctor, Boots Digital Health Limited. Available at: cqc.org.uk/location/1-15661319227 (Accessed: 16 November 2026).
  4. Swarbrick, T. (2026) ‘Boots to become first UK high street pharmacy to privately prescribe cannabis’, LBC, 16 November. Available at: lbc.co.uk (Accessed: 16 November 2026).
  5. The Misuse of Drugs (Amendments) (Cannabis and Licence Fees) (England, Wales and Scotland) Regulations 2018, SI 2018/1055. Available at: legislation.gov.uk (Accessed: 16 November 2026).